logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10994046 B1

PDFFull Text
Date of Patent:
May. 04, 2021

Filed:

Jan. 17, 2019

Hemostatic material, preparation method thereof and pharmaceutical composition containing the same

Applicant:

Gene'e Tech Co., Ltd., Taipei, TW;

Inventors:

Chung-Hao Wang, Taipei, TW;

Shu-Jyuan Yang, Taipei, TW;

Li-Cheng Pan, Taipei, TW;

Assignee:

GENE'E TECH CO., LTD., New Taipei, TW;

Attorney:

Rabin & Berdo, P.C.

Primary Examiner:

Sarah Alawadi

Int. Cl.
CPC ...
A61L 26/00 (2006.01); A61K 38/17 (2006.01); A61K 31/65 (2006.01); A61K 31/635 (2006.01); A61K 31/4439 (2006.01); A61K 31/137 (2006.01); A61K 39/395 (2006.01); A61K 31/728 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61L 26/0052 (2013.01); A61K 31/137 (2013.01); A61K 31/4439 (2013.01); A61K 31/635 (2013.01); A61K 31/65 (2013.01); A61K 31/728 (2013.01); A61K 38/178 (2013.01); A61K 38/1709 (2013.01); A61K 39/3955 (2013.01); A61K 39/39591 (2013.01); A61L 26/008 (2013.01); A61L 26/0023 (2013.01); A61L 26/0038 (2013.01); A61L 26/0066 (2013.01); C07K 16/2839 (2013.01); A61L 2300/418 (2013.01); A61L 2300/45 (2013.01); A61L 2400/04 (2013.01); A61L 2430/34 (2013.01); C07K 2317/24 (2013.01);
Abstract

A hemostatic material, a preparation method thereof, and a pharmaceutical composition containing the same are introduced. The hemostatic material includes 200 to 1600 parts by weight of water-insoluble gelatin and 100 to 1000 parts by weight of hydrating material. The preparation method for the hemostatic material includes the steps of (a) providing 200 to 1600 parts by weight of water-insoluble gelatin and 100 to 1000 parts by weight of hydrating material; and (b) combining the water-insoluble gelatin with the hydrating material to form a hemostatic material. The pharmaceutical composition includes an aforementioned hemostatic material and active pharmaceutical ingredients. Through the aforementioned hemostatic material, hemostatic products can increase the blood absorption capacity.

Find Patent Forward Citations

Loading…